| John Lee, MD | |
|
593 Eddy Street, Department Of Radiology, Providence, RI 02903 | |
| (919) 610-9448 | |
| Not Available |
| Full Name | John Lee |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 8 Years |
| Location | 593 Eddy Street, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740630995 | NPI | - | NPPES |
| MD17642 | Other | RI | RI LICENSE |
| 291819 | Other | MA | MA LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| Roger Williams Medical Center | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rhode Island Medical Imaging | 8022097815 | 108 |
| Rhode Island Medical Imaging | 8022097815 | 108 |
News Archive
Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, announced positive results in the Phase IIa study of its lead product CT327 in atopic dermatitis.
High-grade serious ovarian carcinoma (HGSOC) is the fifth-leading cause of cancer-related deaths in women in the United States, yet little is known about the origins of this disease.
Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture.
A new study presents more empirical evidence that universal masking can reduce transmissibility by almost two-thirds, even with inadequate social distancing. The study was published on the preprint server medRxiv* in November 2020.
› Verified 3 days ago
| Entity Name | Rhode Island Medical Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205874930 PECOS PAC ID: 8022097815 Enrollment ID: O20040715000832 |
News Archive
Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, announced positive results in the Phase IIa study of its lead product CT327 in atopic dermatitis.
High-grade serious ovarian carcinoma (HGSOC) is the fifth-leading cause of cancer-related deaths in women in the United States, yet little is known about the origins of this disease.
Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture.
A new study presents more empirical evidence that universal masking can reduce transmissibility by almost two-thirds, even with inadequate social distancing. The study was published on the preprint server medRxiv* in November 2020.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Lee, MD 593 Eddy St Dept Of, Providence, RI 02903-4923 Ph: (919) 610-9448 | John Lee, MD 593 Eddy Street, Department Of Radiology, Providence, RI 02903 Ph: (919) 610-9448 |
News Archive
Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, announced positive results in the Phase IIa study of its lead product CT327 in atopic dermatitis.
High-grade serious ovarian carcinoma (HGSOC) is the fifth-leading cause of cancer-related deaths in women in the United States, yet little is known about the origins of this disease.
Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture.
A new study presents more empirical evidence that universal masking can reduce transmissibility by almost two-thirds, even with inadequate social distancing. The study was published on the preprint server medRxiv* in November 2020.
› Verified 3 days ago
Lars Stangenberg, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2 Dudley St, Suite 470, Providence, RI 02905 Phone: 401-553-8318 Fax: 401-868-2307 | |
Kara Lynne Leonard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Rih Radiation Oncology, Providence, RI 02903 Phone: 401-444-8311 Fax: 401-444-5335 | |
Michael Low Cardenas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 825 N Main St, Providence, RI 02904 Phone: 774-279-0884 | |
Earle O Assanah, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5174 | |
Glenn A Tung, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-4000 | |
Sarah-kim Shields, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Radiology, Providence, RI 02903 Phone: 401-444-2133 Fax: 401-444-5017 | |
Sean O'neill, MD Radiology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5127 Fax: 401-444-3056 |